Convergence Partners leads a EUR 10 million oversubscribed Pre-Series A funding round for neotiv GmbH, a digital health company focused on early detection of dementia through its innovative neotivCare® app.

Target Information

Neotiv GmbH is a digital health company based in Magdeburg, Germany, established in 2014 as a spin-off from OVGU Magdeburg in collaboration with the German Center for Neurodegenerative Diseases (DZNE). The company specializes in developing mobile applications that assist in the early diagnosis of dementia, particularly Alzheimer's disease. Its flagship product, the CE-marked neotivCare®, provides digital memory assessments aimed at individuals experiencing self-perceived memory issues, facilitating early detection of mild cognitive impairment (MCI).

NeotivCare® employs a unique approach by enabling patients to test specific memory functions related to the initial stages of dementia over a prolonged period. This capability allows for the identification of early Alzheimer's pathology before the onset of visible symptoms, reinforcing the urgency and importance of early diagnosis in dementia care. The company has established partnerships with health insurers and is actively involved in discussions for further collaboration to enhance accessibility of its innovative diagnostics in clinical settings.

Industry Overview

The digital health sector in Germany is experiencing significant growth, driven by increasing awareness and diagnosis of various health conditions, particularly neurodegenerative diseases. The German Alzheimer Society reports approximately 1.8